News | Proton Therapy | October 27, 2015

IBA Announces Upgrades to Penn Medicine Proton Therapy Center Equipment

New advances include cone beam CT, pencil beam scanning technology

Penn Medicine, IBA upgrades, Roberts Proton Therapy Center, PBS, CBCT

October 27, 2015 — IBA announced that longtime customer and research partner Penn Medicine has upgraded the equipment of its Roberts Proton Therapy Center with the latest innovations in proton therapy treatment. This upgrade to the newest technologies will allow Penn Medicine’s staff to continue to offer top-level proton radiation therapy services to an increasing number of patients and to further advance the clinical application of proton therapy.

Penn Medicine treated its first proton patient in March 2010. Research collaborations with IBA are extensive, with Penn Medicine contributing to the research on pencil beam scanning (PBS) protocols and cone beam computed tomography (CBCT), among others. Penn Medicine’s proton therapy facility and experts also play a key role in IBA’s training program, sharing knowledge and experience to contribute to the education of the entire proton therapy community.

Recent acquisitions by the Roberts Proton Therapy Center include:

  • Having taken part in the development and optimization of IBA’s CBCT, Penn Medicine has opted to purchase this image guidance tool, which ensures increased accuracy in patient positioning and brings the center one step closer to adaptive proton therapy treatment;
  • Penn Medicine will replace one of its universal nozzles to a dedicated PBS nozzle. This brings Penn Medicine to a total of four PBS treatment rooms, with one double scattering treatment room remaining. It will allow Penn clinicians to offer the most accurate delivery of proton therapy currently available to a larger number of patients, while maintaining the advantage double scattering provides when treating moving targets. This adapted configuration provides Penn Medicine with the option to cover a very broad range of indications, with fixed as well as moving targets; and
  • For research purposes, Penn Medicine will also deploy the Universal Monitoring Interface (UMI) and Adapt Analytics software. These software applications are used to monitor how much time is spent on and by the patient at different treatment stages. The aim of this research is to improve the workflow efficiency in order to optimize throughput. Ultimately, it will allow more patients, at Penn Medicine and elsewhere, to benefit from proton therapy treatment.

The current Penn Medicine upgrade exceeds $3 million USD, and IBA still has a general pipeline left of $7 million.

James Metz, M.D., chair of Penn Medicine Department of Radiation Oncology, commented, “The clinical application of proton therapy is a medical field in full evolution. At Penn Medicine, we believe in its potential and are fully committed to helping its realization, leveraging topnotch technology to make sure that as many eligible patients as possible can benefit from this radiation therapy modality, now and in the future.”

For more information: www.iba-worldwide.com

Related Content

FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S.
Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc.